These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8907427)

  • 1. [The mechanisms of the formation of heterologous resistance in peroral immunization with a complex anti-influenza preparation].
    Markevich NA; Maslennikova II; Pokrovskaia EE; Osipova MV; Ispolatova AV
    Vestn Ross Akad Med Nauk; 1996; (1):51-4. PubMed ID: 8907427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunization with a complex preparation: a new method of influenza prevention. The basis for using a complex preparation for preventing influenza].
    Shvartsman IaS; Ispolatova AV; Tsybul'skaia NV; Shapiro NI; Aksenov OA
    Vopr Virusol; 1982; 27(2):142-6. PubMed ID: 6178215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined use of interferon inducers and recombinant influenza viruses for protection from the disease].
    Podcherniaeva RIa; Shchipanova MV; Nosik NN; Ershov FI; L'vov DK
    Vopr Virusol; 1984; 29(2):173-5. PubMed ID: 6203227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily intake of heat-killed Lactobacillus plantarum L-137 enhances type I interferon production in healthy humans and pigs.
    Arimori Y; Nakamura R; Hirose Y; Murosaki S; Yamamoto Y; Shidara O; Ichikawa H; Yoshikai Y
    Immunopharmacol Immunotoxicol; 2012 Dec; 34(6):937-43. PubMed ID: 22468623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary whole glucan particles do not affect antibody or cell-mediated immune responses to influenza virus vaccination in mice.
    Pence BD; Hester SN; Donovan SM; Woods JA
    Immunol Invest; 2012; 41(3):275-89. PubMed ID: 22149961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model.
    Ninomiya A; Imai M; Tashiro M; Odagiri T
    Vaccine; 2007 May; 25(18):3554-60. PubMed ID: 17293015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC; Johansson BE
    Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study of the effectiveness of inactivated chromatographic influenza vaccine prepared from the native and recombinant strains of influenza virus].
    Rozaeva NR; Bichurina MA; Fridman EA
    Vopr Virusol; 1989; 34(6):738-41. PubMed ID: 2633468
    [No Abstract]   [Full Text] [Related]  

  • 11. A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system.
    Youn HJ; Ko SY; Lee KA; Ko HJ; Lee YS; Fujihashi K; Boyaka PN; Kim SH; Horimoto T; Kweon MN; Kang CY
    Vaccine; 2007 Jul; 25(28):5189-98. PubMed ID: 17548137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG antibodies mediate protective immunity of inactivated vaccine for highly pathogenic H5N1 influenza viruses in ferrets.
    Shin JS; Kim HS; Cho SH; Seo SH
    Viral Immunol; 2010 Jun; 23(3):321-7. PubMed ID: 20565295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Increased effectiveness of influenza prevention vaccination by using levamisole].
    Pavlishin VV; Savtsova ZD; Giulling EV
    Vopr Virusol; 1984; 29(2):248-50. PubMed ID: 6730442
    [No Abstract]   [Full Text] [Related]  

  • 14. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine.
    Vincent AL; Lager KM; Janke BH; Gramer MR; Richt JA
    Vet Microbiol; 2008 Jan; 126(4):310-23. PubMed ID: 17719188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvanted inactivated influenza A(H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines.
    Ann J; Samant M; Rheaume C; Dumas C; Beaulieu E; Morasse A; Mallett C; Hamelin ME; Papadopoulou B; Boivin G
    Vaccine; 2014 Sep; 32(43):5730-9. PubMed ID: 25173481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.
    Itoh Y; Ozaki H; Tsuchiya H; Okamoto K; Torii R; Sakoda Y; Kawaoka Y; Ogasawara K; Kida H
    Vaccine; 2008 Jan; 26(4):562-72. PubMed ID: 18164788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and immunological characteristics of the emulsion form of inactivated influenza vaccine delivered by oral immunization.
    Avtushenko SS; Sorokin EM; Zoschenkova NY; Zacharova NG; Naichin AN
    J Biotechnol; 1996 Jan; 44(1-3):21-8. PubMed ID: 8717382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral immunization against respiratory viruses in mice.
    Nedrud J; Sigmund N; Brunschwig E; Lamm M
    Adv Exp Med Biol; 1995; 371B():1595-8. PubMed ID: 7502863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adjuvant effect of Sophy β-glucan to the antibody response in poultry immunized by the avian influenza A H5N1 and H5N2 vaccines.
    Le T; Le T; Doan TH; Quyen D; Le KX; Pham V; Nagataki M; Nomura H; Ikeue Y; Watanabe Y; Agatsuma T
    J Microbiol Biotechnol; 2011 Apr; 21(4):405-11. PubMed ID: 21532325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine.
    Hagenaars N; Verheul RJ; Mooren I; de Jong PH; Mastrobattista E; Glansbeek HL; Heldens JG; van den Bosch H; Hennink WE; Jiskoot W
    J Control Release; 2009 Dec; 140(2):126-33. PubMed ID: 19712713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.